LaNua Medical, a brand new medical technology startup and has closed seed funding of €6 million. The funding will advance the commercialization of the company‘s novel Ecore device. It is intended to enhance the safety, efficacy, and efficiency of embolization procedures applied to tackle DAVFs, hemorrhage, and a myriad of tumors.